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Incompatible Blood Transfusions in Liver Transplant Patients with 
Significant Red Cell Alloantibodies 
G. Ramsey, F.W. Cornell, L.F. Hahn, F. Fonzi, and T.E. Starzl 
L IVER TRANSPLANT patients often need large 
amounts of blood. I The presence of significant red 
blood cell (RBC) alloantibodies in these patients complicates 
the blood bank's ability to provide the necessary blood 
products. In the first 1000 liver transplantations performed 
at our center, 13.7% of adults and 6.3% of children had 
significant RBC alloantibodies.2 We now have had 17 
patients with significant RBC antibodies, rapid surgical 
blood need, and use of potentially incompatible blood 
untested for offending antigens. (Eight cases were noted 
previously.2) In this report we analyze our growing experi-
ence, characterize the cases according to outcome, and 
discuss our blood bank's approach to this problem. 
MATERIALS AND METHODS 
We reviewed the Central Blood Bank's transfusion service records 
for all liver transplantations at the University of Pittsburgh from 
February 1981 to July 1988. From about 1500 transplantations, 17 
were identified in which potentially incompatible blood had to be 
given despite current and previous existence of significant antibod-
ies. We tabulated the amount and sequence of RBCs (whole blood or 
packed cells) issued, and reviewed antibody studies and clinical 
records for evidence of subsequent immune hemolysis: otherwise 
unexplained decrease in hematocrit, increase in indirect bilirubin, 
and positive direct antiglobulin test (OAT) due to alloantibody. 
RESULTS 
The 17 patients had 28 significant antibodies (15 Rh, 8 Kell, 
3 Kidd (Jk), 2 Duffy (Fy». They received an average of 70 
units of RBCs (median 67, range 11-160). All patients 
received ~U units of antigen-negative RBCs before untyped 
blood was given. Six patients survived, and II died between 
0-48 days. These findings are consistent with the reported 
correlation of high blood use with a lower survival rate.) The 
patients were classified as follows: hemolysis occurred in 2, 
no hemolysis in S, analysis pending (chart sought) in I, and 
in 9 patients, .:52 units of incompatible RBCs were given (5) 
and/or death occurred within 3 days (4). Patient 1 with 
hemolysis was a l4-year-old with a delayed reaction from 
anti-Fy'. Patient 2 with hemolysis was a 29-year-old 0 Rh-
woman with Budd-Chiari syndrome due to paroxysmal noc; 
tumal hemoglobtnuria (PNH), and anti-D and -c. After 
pretransplantation red cell exchange, she was given 12 units 
of Rh + RBCs during surgery (86 total units) because of a 
low supply of 0 Rh -, and also unintentionally given 2 units 
of group A RBCs, which may have caused coagulopathy 
resulting in retransplantation the next day. Twenty of 64 
subsequent units of RBCs were also Rh+, including some 
given during a third transplantation at day 5. Hemolysis 
ensued from day 8 to death at day 13 from sepsis and hepatic 
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thrombosis. A positive DA T and then reversion to Rh-
typing before death suggested destruction of Rh + RBCs, but 
hemolysis of any residual PNH RBCs may have contributed. 
The five patients without hemolysis had the following anti-
bodies, estimated antigen-positive RBCs, and total units of 
RBCs given: (1) e+E, 86/155; (2) E+K, 33/100; (3) 
E+K+Jk', 29/45; (4) Jk", 22/39; (5) E, 15/78. In cases 3 
and 5 these were prior antibodies not detected at surgery. 
Patients I and 4 died at 26 and 34 days. 
DISCUSSION 
The likelihood of acute hemolysis was lessened in these 17 
patients by (I) initial transfusion of ~U units of antigen-
negative blood and (2) the known absence of complement 
fixation by Rh antibodies, the most common ones involved. 
Seven patients receiving substantial numbers of incompati-
ble RBCs were at risk of delayed hemolysis after surviving 
> 7 days; two had clinical evidence of hemolysis, but one was 
complicated by an intrinsic hemolytic defect of her own 
RBCs (PNH). Corticosteroids may suppress phagocytic 
immune RBC destruction in these patients. We attempted to 
reserve some antigen-negative RBCs until the end of surgery, 
but the timing was difficult to achieve. Another delayed 
hemolytic reaction following liver transplantation has been 
described.4 
In patients with difficult RBC antibody problems, we 
strive to have the first 10 or more units as antigen-negative. 
When large numbers of incompatible RBCs were necessary, 
most surviving patients (5 of 7) had no significant delayed 
hemolysis. Our only patient with anti-D who got Rh+ RBCs 
had hemolysis, but underlying PNH made evaluation diffi-
cult. 
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